BIO.B: Bio-Rad Laboratories, Inc. Class B Company Profile & Statistics

About

BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Info & Links

CEO

Norman Schwartz

Headquarters

1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547, UNITED STATES

Auditor

KPMG LLP

Share holders

226

Employees

7,700

Bio-Rad Laboratories, Inc. Class B Statistics

Valuation Measures

Market Capitalization²

7.07B

Enterprise Value

7.79B

Enterprise Value/EBITDA(ttm)

28.94

Price to Earnings Ratio(ttm)

30.27

Price to Sales(ttm)

3.41

Price to Book(mrq)

1.33

Price to Cash(ytd)

30.03

Profitability

Gross Margin(ttm)

53.75%

Operating Margin(ttm)

11.35%

Profit Margin(ttm)

-70.76%

Return on Equity(ttm)

3.90%

Return on Invested Capital(ttm)

-25.09%

Return on Assets(ttm)

2.76%

Income Statement

Revenue(ttm)

2.57B

Revenue Per Share(ttm)

91.62

Gross Profit(ttm)

1.38B

EBITDA(ttm)³

269.00M

Net Income Available to Common(ttm)

-1.84B

Diluted EPS(ttm)

-65.04

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-11.56%

S&P 500 52-Week Change

10.97%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

28.01M

Dividend Yield

0.00%

Float⁴

20.05M

% Held by Insiders

28.38%

% Held by Institutions

0.01%

Balance Sheet

Total Cash(mrq)

1.66B

Total Cash Per Share(mrq)

59.42

Total Debt(mrq)

1.20B

Total Debt/Equity(mrq)

18.29%

Current Ratio(mrq)

6.48%

Quick Ratio(mrq)

4.85%

Book Value Per Share(mrq)

234.53

Cash Flow

Operating Cash Flow Per Share(ytd)

16.13

Free Cash Flow(ytd)

289.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BIO.B

Bio-Rad Laboratories, Inc. Class B

Bio-Rad Laboratories, Inc. Class B Profile